Patents by Inventor Hugues Wallemacq

Hugues Wallemacq has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic composition
    Patent number: 10130694
    Abstract: The present invention relates to immunogenic compositions comprising a Clostridium difficile (C. difficile) polypeptide and an aluminum-free adjuvant.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: November 20, 2018
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Dominique Boutriau, Sophie Marie Jeanne Valentine Germain, Hugues Wallemacq
  • IMMUNOGENIC COMPOSITION
    Publication number: 20170340719
    Abstract: The present invention relates to immunogenic compositions comprising a Clostridium difficile (C. difficile) polypeptide and an aluminium-free adjuvant.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Dominique BOUTRIAU, Sophie Marie Jeanne Valentine GERMAIN, Hugues WALLEMACQ
  • Immunogenic composition
    Patent number: 9694064
    Abstract: The present invention relates to immunogenic compositions comprising a Clostridium difficile (C. difficile) polypeptide and an aluminum-free adjuvant.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: July 4, 2017
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Dominique Boutriau, Sophie Marie Jeanne Valentine Germain, Hugues Wallemacq
  • IMMUNOGENIC COMPOSITION
    Publication number: 20150313984
    Abstract: The present invention relates to immunogenic compositions comprising a Clostridium difficile (C.difficile) polypeptide and an aluminium-free adjuvant.
    Type: Application
    Filed: December 3, 2013
    Publication date: November 5, 2015
    Inventors: Dominique BOUTRIAU, Sophie Marie Jeanne Valentine GERMAIN, Hugues WALLEMACQ
  • VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE
    Publication number: 20140072622
    Abstract: The present invention relates to improved immunogenic compositions and vaccines, methods for making them and their use in medicine. In particular the invention relates to immunogenic compositions of unconjugated Streptococcus pneumoniae proteins selected from: pneumolysin and member(s) of the Polyhistidine Triad family (e.g. PhtD), which comprise adjuvants comprising QS21 and monophosphoryl lipid A (MPL), and are presented in the form of a liposome.
    Type: Application
    Filed: May 15, 2012
    Publication date: March 13, 2014
    Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Philippe Denoel, Jan Poolman, Vincent Verlant, Hugues Wallemacq